MARKET

ZURA

ZURA

Zura Bio Limited
NASDAQ
4.040
+0.190
+4.94%
After Hours: 4.040 0 0.00% 19:38 10/30 EDT
OPEN
3.810
PREV CLOSE
3.850
HIGH
4.060
LOW
3.655
VOLUME
4.08M
TURNOVER
--
52 WEEK HIGH
7.44
52 WEEK LOW
3.250
MARKET CAP
391.08M
P/E (TTM)
-3.6600
1D
5D
1M
3M
1Y
5Y
1D
Zura Bio files $700M mixed securities shelf
TipRanks · 3d ago
Zura Bio Files Prospectus To Offer Up To $700M Of Securities
Benzinga · 3d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 4d ago
Zura Bio GAAP EPS of -$0.20 in-line
Seeking Alpha · 4d ago
Wedbush would be ‘aggressive buyer’ of Zura Bio ahead of key Q4 catalyst
TipRanks · 4d ago
Zura Bio Highlights Q3 Results and Tibulizumab Progress
TipRanks · 4d ago
Zura Bio reports Q3 EPS (20c), consensus (21c)
TipRanks · 4d ago
Zura Bio sees cash runway through at least the end of 2028
TipRanks · 4d ago
More
About ZURA
Zura Bio Limited is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies. It is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880) with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases, including systemic sclerosis and other indications with unmet needs. ZB-106 is an immunoglobulin G single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of TALTZ and tabalumab that neutralize interleukin-17A (IL-17A) and BAFF. ZB-168 is a fully human, high affinity monoclonal antibody that binds and neutralizes the IL-7 receptor chain alpha chain. ZB-880 is a fully human, high affinity monoclonal antibody that neutralizes IL-33, preventing ST2-dependent and ST2-independent inflammation.

Webull offers Zura Bio Ltd stock information, including NASDAQ: ZURA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZURA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZURA stock methods without spending real money on the virtual paper trading platform.